Esperion Therapeutics ESPR Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's common stock, shares issued (in shares)?
- Esperion Therapeutics (ESPR) reported common stock, shares issued (in shares) of $259.4M in Q1 2026.
- How has Esperion Therapeutics's common stock, shares issued (in shares) changed year-over-year?
- Esperion Therapeutics's common stock, shares issued (in shares) increased by 30.6% year-over-year, from $198.65M to $259.4M.
- What is the long-term trend for Esperion Therapeutics's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Esperion Therapeutics's common stock, shares issued (in shares) has grown at a 54.7% compound annual growth rate (CAGR), from $27.91M to $247.21M.